DHR vs HON: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Honeywell International Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Honeywell International Inc. · Industrials
$212.55
-8.5% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
HON |
| Current Price |
$221.12 |
$212.55 |
| Fair Value Estimate |
$286.52 |
$194.50 |
| Upside to Fair Value |
+29.6%
|
-8.5%
|
| Market Cap |
$155.4B |
$67.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
7.4x
|
| Price / Sales |
6.2x
|
1.9x
|
| Price / FCF |
28.5x
|
16.4x
|
| Revenue Growth YoY |
+5.5%
|
-6.1%
|
| Gross Margin |
58.5%
|
36.6%
|
| Operating Margin |
20.4%
|
14.1%
|
| Return on Equity |
7.7%
|
41.7%
|
| Dividend Yield |
0.65% |
2.09% |
| FCF Yield |
3.51%
|
6.11%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Honeywell International Inc. is a 101,000-employee diversified industrial technology and manufacturing conglomerate, led by CEO Vimal Kapur, spanning Aerospace, Building Technologies, Performance Materials and Technologies, and Safety and Productivity Solutions. Business quality is solid but not exceptional: the company carries a durable intangible-asset and switching-cost moat in aerospace avion…
Accumulation Zones
| Metric |
DHR |
HON |
| Zone Low |
$214.89 |
$145.88 |
| Zone High |
$243.54 |
$165.32 |
| In Buy Zone? |
Yes
|
No
|